Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

BUY
$3.22 - $7.53 $6,140 - $14,359
1,907 Added 59.26%
5,125 $30,000
Q1 2023

May 15, 2023

SELL
$3.11 - $4.92 $7,852 - $12,423
-2,525 Reduced 43.97%
3,218 $10,000
Q4 2022

Jun 14, 2023

BUY
$3.19 - $6.46 $8,054 - $16,311
2,525 Added 78.46%
5,743 $22.7 Million
Q3 2022

Jun 14, 2023

BUY
$5.58 - $9.04 $14,089 - $22,825
2,525 Added 78.46%
5,743 $34.5 Million
Q2 2022

Jun 20, 2023

BUY
$4.12 - $9.35 $10,403 - $23,608
2,525 Added 78.46%
5,743 $36,000
Q1 2022

Jun 20, 2023

BUY
$5.24 - $15.58 $13,231 - $39,339
2,525 Added 78.46%
5,743 $47,000
Q1 2022

Mar 30, 2023

SELL
$5.24 - $15.58 $91,925 - $273,319
-17,543 Reduced 75.34%
5,743 $47,000
Q1 2022

May 12, 2022

SELL
$5.24 - $15.58 $91,925 - $273,319
-17,543 Reduced 75.34%
5,743 $47,000
Q4 2021

Jun 21, 2023

BUY
$15.18 - $23.15 $304,632 - $464,574
20,068 Added 623.62%
23,286 $360,000
Q3 2021

Jun 21, 2023

BUY
$16.29 - $25.88 $326,907 - $519,359
20,068 Added 623.62%
23,286 $524,000
Q3 2021

Mar 30, 2023

BUY
$16.29 - $25.88 $234,836 - $373,086
14,416 Added 162.53%
23,286 $524,000
Q3 2021

Nov 15, 2021

BUY
$16.29 - $25.88 $234,836 - $373,086
14,416 Added 162.53%
23,286 $524,000
Q2 2021

Jun 21, 2023

BUY
$16.65 - $32.14 $94,105 - $181,655
5,652 Added 175.64%
8,870 $174,000
Q2 2021

Mar 30, 2023

BUY
$16.65 - $32.14 $124,475 - $240,278
7,476 Added 536.3%
8,870 $174,000
Q2 2021

Aug 16, 2021

BUY
$16.65 - $32.14 $147,668 - $285,049
8,869 Added 886900.0%
8,870 $174,000
Q1 2021

Jun 26, 2023

SELL
$23.04 - $43.5 $38,545 - $72,775
-1,673 Reduced 51.99%
1,545 $51.7 Million
Q1 2021

Mar 30, 2023

SELL
$23.04 - $43.5 $100,200 - $189,181
-4,349 Reduced 75.73%
1,394 $46,000
Q1 2021

May 14, 2021

BUY
$23.04 - $43.5 $23 - $43
1 New
1 $47,000

Others Institutions Holding SANA

About Sana Biotechnology, Inc.


  • Ticker SANA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 190,232,000
  • Market Cap $314M
  • Description
  • Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...
More about SANA
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.